SHIRLEY, NY, UNITED STATES – Feb 14, 2019-CD Genomics, the USA-based genetic sequencing company, recently announces the launch of its proprietary GenSeqTM Technology to provide comprehensive diversity analysis services.
Prokaryotes (domain archaea and bacteria) are single-celled organisms that lack the nucleus. They have a single piece of circular prokaryotic DNA in the nucleoid area of the cell. Most prokaryotes have cell walls outside the plasma membrane. The cell membrane composition and the characteristics of cell walls of bacteria and archaea are different. The advent of DNA sequencing provided immense insight into the relationships and origins of prokaryotes that could not be achieved using traditional classification methods. A major insight identified two groups of prokaryotes that were found to be as different from each other as they were from eukaryotes. This recognition of prokaryotic diversity forced a new understanding of the classification of all life and brought us closer to understanding the fundamental relationships of all living things, including ourselves.
Under the setting of rapid progress in the development of next-generation sequencing (NGS) technologies, this field has provided many valuable insights into complex biological systems and dramatically advanced cell biology. For example, from cancer genomics to diverse microbial identification. It has been treated as a promising tool for approaching a set of seemingly inaccessible problems. For example, heterogeneous samples, rare cell types, cell lineage relationships, mosaicism of somatic tissues, analyses of microbes that cannot be cultured, and disease evolution can all be elucidated through single cell sequencing. With such progress, researchers are now increasingly moving their focus from whole to the characterization of individual cells-based technologies for genomics, transcriptomics, and epigenomics.
The analysis of amplified and sequenced has recently become one of the most important approaches for microbial diversity and identification studies. New sequencing technologies allow for sequencing millions of reads and many samples in a single run through our multiplexing strategies. This is usually accomplished through PCR amplification followed by sequencing a portion of the 16S ribosomal RNA gene. The generated data is then compared to validated microbial sequencing databases. CD Genomics have the capability to compare your results against databases curated in the house for special applications, or against publicly accessible databases. One of the specialties of the service is the evaluation of microbial diversity using tagged or barcoded approaches. In fact, CD Genomics pioneered many aspects of these approaches. They have a wide variety of assays available and are always ready to help develop custom assays.
“CD Genomics concentrates on supplying the high-quality services and products for labs and research institutes. We guarantee the developed products and services, which are customized, can meet the demands of our clients, who believe in our scientists and CD Genomics”, said Dr. David.
About CD Genomics
CD Genomics is a world-leading Genomics Services Company that innovates sequencing services, as well as genotyping, library construction, bioinformatics, aptamers, microarray, health diagnostics, mutagenesis analyses and others for the genomics industry.
Company Name: CD Genomics
Contact Person: Kiko Garcia
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States